Prevention and treatment of epstein-barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

This publication has 91 references indexed in Scilit:

• MOLECULAR PATHOGENESIS OF EPSTEIN-BARR VIRUS ASSOCIATED POSTTRANSPLANT LYMPHOMAS: NEW INSIGHTS THROUGH LATENT MEMBRANE PROTEIN 1 FINGERPRINTING1
  Transplantation, 2001
• Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients
  Transplantation and Cellular Therapy, 2001
• Epstein–Barr Virus Infection
  New England Journal of Medicine, 2000
• Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection
  Transplant International, 2000
• Posttransplantation lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome
  Liver Transplantation and Surgery, 1999
• Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma
  Annals of Neurology, 1999
• B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome
  Bone Marrow Transplantation, 1999
• Acyclovir and Prednisolone Treatment of Acute Infectious Mononucleosis: A Multicenter, Double-Blind, Placebo-Controlled Study
  The Journal of Infectious Diseases, 1996
• Transmission of donor Epstein--Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients
  Journal of General Virology, 1996
• Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ Transplantation
  New England Journal of Medicine, 1991